Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1

The Lancet Haematology

Haematological malignancies are a heterogeneous group of diseases with diverse incidence. In Europe, the median age at diagnosis across all disease entities is 69 years. Incidence generally increases with age, reaching a maximum at 75–99 years, with the notable exceptions of Hodgkin lymphoma and acute lymphocytic leukaemia. Overall survival for patients aged 75 years and older with haematological...

  • 123456 Profile photo of Madelyn

    Here is a nice review of treatment of older patients with hematologic malignancies – there is a very nice section on the treatment and data re: DLBCL treatment and CNS prophylaxis.